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The empirical and pragmatic nature of diagnostic microbiology has given rise to several
different schemes to subtype E.coli, including biotyping, serotyping, and pathotyping.
These schemes have proved invaluable in identifying and tracking outbreaks, and for
prognostication in individual cases of infection, but they are imprecise and potentially
misleading due to the malleability and continuous evolution of E. coli. Whole genome
sequencing can be used to accurately determine E. coli subtypes that are based on
allelic variation or differences in gene content, such as serotyping and pathotyping. Whole
genome sequencing also provides information about single nucleotide polymorphisms in
the core genome of E. coli, which form the basis of sequence typing, and is more reliable
than other systems for tracking the evolution and spread of individual strains. A typing
scheme for E. coli based on genome sequences that includes elements of both the core
and accessory genomes, should reduce typing anomalies and promote understanding
of how different varieties of E. coli spread and cause disease. Such a scheme could also
define pathotypes more precisely than current methods.
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Escherichia coli is the most comprehensively studied bacterium on earth. Because it is relatively
easy to manipulate genetically, it has become a popular laboratory workhorse. Its natural habitat,
however, is the intestinal tract of humans and other mammals. For this reason it is used in public
health as an indicator of faecal contamination of water and other consumables.
Despite its ubiquity as a commensal, E. coli is also an important pathogen of humans and
domestic animals. It can become established and cause disease in tissues other than the intestinal
tract. These so-called extraintestinal pathogenic E. coli (ExPEC) are important causes of wound
infection, urinary tract infection, peritonitis, pneumonia, meningitis, and septicaemia. The ExPEC
group includes named subtypes, such as uropathogenic E. coli (UPEC), neonatal meningitis-
associated E. coli (NMEC), and sepsis-associated E. coli (SEPEC) (Pitout, 2012; Leimbach et al.,
2013).
Infections caused by ExPEC are usually opportunistic, i.e., they occur most often in hosts
who are compromised in some way, such as by having a dysfunctional urinary tract or systemic
immunocompromise due to neutropenia or extremes of age. Nevertheless, some ExPEC strains are
better equipped to cause extraintestinal infections than others due to factors that facilitate their
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ability to colonise tissues. These include type I fimbriae,
pyelonephritis-associated pili (PAP), and AfA/Dr adhesins in
the case of UPEC, or the K1 polysaccharide capsule, which
allows NMEC and SEPEC to evade complement-mediated killing
(Pitout, 2012; Leimbach et al., 2013).
The pathotypes of E. coli that are associated with intestinal
disease are known collectively as intestinal pathogenic E. coli
(IPEC) or diarrheagenic E. coli (DEC)—although not all of
the subtypes in this group necessarily cause diarrhoea. The
individual pathotypes of DEC include enteropathogenic E. coli
(EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli
(ETEC), enterohemorrhagic E. coli (EHEC), enteroaggregative E.
coli (EAEC), diffusely-adherent E. coli (DAEC), and adherent-
invasive E. coli (AIEC) (Nataro and Kaper, 1998; Kaper et al.,
2004; Croxen et al., 2013). In addition, the entire genus Shigella
is a DEC pathotype, which closely resembles EIEC in terms
of virulence attributes and pathogenicity, but is distinguishable
from other strains of E. coli by virtue of its biochemical activity
(Lan et al., 2004). Accordingly, shigellae can be regarded as
members of the EIEC pathotype.
Each DEC pathotype represents a collection of strains that
possess similar virulence factors to each other and cause similar
diseases with similar pathology. Unlike ExPEC, where there are
no specific virulence determinants that exclusively define each
subtype, most DEC pathotypes are defined by the possession
of one or more pathotype-specific virulence markers, and
sometimes by the absence of others. Several of the defining
markers of DEC pathotypes are proven virulence determinants
of that pathotype, but for EAEC, DAEC, and AIEC the role of
these markers in virulence is not proven (Table 1).
DEC PATHOTYPES
In this section, we provide a brief overview of DEC pathotypes
with an emphasis on their defining characteristics and key
virulence determinants (where known). We also point out some
important gaps in the understanding of certain pathotypes.
For more detailed information on DEC in general, readers are
referred to reviews by Nataro and Kaper (1998), Kaper et al.
(2004), Clements et al. (2012), and Croxen et al. (2013). In the
bibliography, we have also included references to review articles
dealing with individual DEC pathotypes.
Enteropathogenic E. coli (EPEC)
EPEC was the first pathotype of DEC to be discovered, and is an
important cause of diarrhoea and premature death in children,
especially in developing countries (Robins-Browne, 1987). As
a group, EPEC is characterised by the presence of the locus
of enterocyte effacement (LEE) pathogenicity island (McDaniel
and Kaper, 1997; Robins-Browne and Hartland, 2002; Croxen
et al., 2013). This∼40-kbp island encodes (i) an outer membrane
adhesive protein, known as intimin that is encoded by the
eae gene, (ii) a type 3 protein secretory system, (iii) several
type 3-secreted effectors, including the Tir protein which is the
translocated receptor for intimin (Kenny et al., 1997).
Expression of the LEE is associated with distinctive attaching-
effacing lesions in the intestinal epithelium which characterise
EPEC pathology (Moon et al., 1983; Tzipori et al., 1985). Almost
all genes within the LEE are required for the production of
these lesions, and studies in adult volunteers have demonstrated
that intimin and EspB, a key component of the type 3
secretion system, are essential virulence determinants of EPEC
(Donnenberg et al., 1993; Tacket et al., 2000). An accessory
virulence determinant, which EPEC also requires for virulence
in humans, is the bundle-forming pilus (BFP) (Girón et al., 1991;
Bieber et al., 1998). Some human isolates of EPEC naturally lack
BFP, but may cause disease (Trabulsi et al., 2002; Nguyen et al.,
2006). These strains, known as atypical EPEC are associated with
persistent diarrhoea in children (Nguyen et al., 2006). Atypical
EPEC are genetically diverse and appear to vary in virulence
(Tennant et al., 2009; Ingle et al., 2016a).
Enterohemorrhagic E. coli (EHEC)
EHEC first came to attention as the cause of two outbreaks
of haemorrhagic colitis (HC) in the USA during 1982 (Riley
et al., 1983). The defining virulence determinant of EHEC
is the phage-encoded Shiga toxin (also known as Verotoxin),
of which there are several varieties (O’Loughlin and Robins-
Browne, 2001; Melton-Celsa et al., 2012). Although volunteer
studies with EHEC are prohibited for ethical reasons, vast
quantities of epidemiological data leave no doubt that Shiga toxin
is responsible for the life-threatening manifestations of EHEC
infections, namely, HC and the haemolytic uraemic syndrome
(HUS). Evidence supporting a role for Shiga toxin in these
conditions include the observation that infections with other
bacteria which produce Shiga toxin, such as Shigella dysenteriae
serotype 1 and occasional strains of EAEC, may also cause HC
and HUS (Rohde et al., 2011; Walker et al., 2012).
Not all strains of Shiga toxin-producing E. coli (STEC or
VTEC) cause HC or HUS, and the term “EHEC” is generally
reserved for those that do. Thus, although all EHEC are STEC,
not all STEC are EHEC. The properties that distinguish EHEC
from those STEC that do not cause HC or HUS are accessory
virulence factors which allow the bacteria to adhere to the
intestinal epithelium, such as the LEE pathogenicity island in so-
called “typical EHEC” or a number of other adhesins that are
present in LEE-positive and/or LEE-negative strains (reviewed in
McWilliams and Torres, 2014).
Typical EHEC strains of serotype O157:H7 also generally
carry a virulence-associated plasmid, known as pO157, which
encodes a number of putative virulence determinants (Burland
et al., 1998). Related plasmids occur in EHEC of other
serogroups, including O26, O103, O111, and O145 (Ogura
et al., 2009). One of the virulence-associated factors encoded
by these plasmids is a serum-sensitive haemolysin, known
as EHEC haemolysin or enterohaemolysin. Many EHEC
isolates produce this protein, including some that carry
plasmids only distantly related to pO157 (Beutin et al., 1989).
Accordingly, the production of enterohaemolysin can be used as
a diagnostic marker of EHEC (Feldsine et al., 2016). Interestingly,
enterohaemolysin is also produced by some LEE-positive, Shiga
toxin-negative strains of E. coli obtained from cattle and sheep
(Cookson et al., 2007). This observation provides evidence of
the evolutionary relationship between atypical EPEC and EHEC,
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TABLE 1 | Virulence-associated markers of diarrheagenic E. coli from humans.
Pathotype Defining marker Essential virulence
determinant(s)
Location of essential
virulence determinant(s)
Major diagnostic
target(s) for PCR
Other diagnostic
target(s)
EPEC LEE PAI LEE PAI Pathogenicity island eae bfpAa
EIEC/Shigella pINV pINV Plasmid ipaH Other ipa genes
ETEC ST or LT ST and/or LT plus colonisation
factors
Plasmid; transposon elt, est
EHEC Shiga toxin Shiga toxin 1 and/or 2 Prophages stx1, stx2 eaea, ehxAa
EAEC pAA; aggregative adhesion Not known Plasmid (probably); possibly
others
aggR, aatA, aaiC
DAEC Afa/Dr adhesins Not known Not known Afa/Dr adhesinsb
AIEC Adherent-invasive phenotype Not known Not known none none
aaiC, gene for a secreted protein of enteroaggregative E. coli; aatA, gene for a transporter protein of enteroaggregative E. coli; Afa, afimbrial adhesin; aggR, gene for a transcriptional
regulator; AIEC, adherent-invasive E. coli; bfpA, gene for a structural protein of bundle-forming pili; DAEC, diffusely-adherent E. coli; EAEC, enteroaggregative E. coli; EIEC, enteroinvasive
E. coli; elt, gene for heat-labile enterotoxin; EPEC, enteropathogenic E. coli; est, gene for heat-stable enterotoxin; ETEC, enterotoxigenic E. coli; ipaH, gene for a type 3-secreted effector
protein of enteroinvasive E. coli and Shigella; LEE PAI, locus of enterocyte effacement pathogenicity island; LT, heat-labile enterotoxin; pAA, virulence plasmid of enteroaggregative E.
coli; pINV, virulence plasmid of enteroinvasive E. coli and Shigella; ST, heat-stable enterotoxin.
aNot present in all strains.
bThese are under review following concerns about specificity.
which is also evident from the high degree of relatedness between
atypical EPEC strains of serotype O55:H7 and EHEC O157:H7
(Feng et al., 1998).
Enterotoxigenic E. coli (ETEC)
ETEC is a leading cause of diarrhoea in children in developing
countries and in travellers to these countries (Qadri et al., 2005;
Lanata et al., 2013). ETEC is also an important cause of diarrhoea
in domestic animals, notably calves and piglets, where ETEC-
induced diarrhoea is of considerable economic importance (Nagy
and Fekete, 1999; Fairbrother et al., 2005).
As the name suggests, the ETEC pathotype is defined by the
capacity of the bacteria to produce one or more enterotoxins. In
ETEC the specific enterotoxins are the heat-labile and heat-stable
enterotoxins (LT and ST) and their various subtypes (Qadri et al.,
2005). The two major subtypes of ST are STa (also known as STI)
and Stb (STII), of which only STa is important in humans (Qadri
et al., 2005; Taxt et al., 2010). Most ETEC strains isolated from
humans with diarrhoea produce STa, often together with LT. The
role of each of these toxins in disease has been established in
volunteer studies (Levine et al., 1977, 1979).
Both ST and LT exert their maximum impact on water and
electrolyte transport in the small intestine. In order to deliver
these toxins to the small intestinal epithelium, ETEC need
to attach to epithelial cells, which they achieve by means of
specific colonisation factors (Qadri et al., 2005; Madhavan and
Sakellaris, 2015). These factors are highly variable structurally
and antigenically, and also differ between isolates from humans
and animals. In several instances, the role of colonisation factors
as accessory virulence determinants has been demonstrated
experimentally (Qadri et al., 2005; Madhavan and Sakellaris,
2015).
Enteroinvasive E. coli (EIEC)
EIEC are closely related to Shigella, especially in terms of
the disease they cause, i.e., bacillary dysentery, and their key
virulence determinant: a plasmid known as pINV. This plasmid
encodes a type 3 secretion system and a number of effectors that
allow shigellae/EIEC to penetrate epithelial cells, move within
these cells and invade neighbouring cells (Marteyn et al., 2012).
Both shigellae and EIEC carry several other putative virulence
determinants including adhesins and secreted toxins, but pINV,
which appears to be restricted to these bacteria, is the key to their
virulence (Marteyn et al., 2012; Croxen et al., 2013).
EIEC and shigellae exemplify the changes that E. coli can
make to adjust to a pathogenic lifestyle (Day et al., 2001). Thus,
by acquiring pINV, and other genetic elements that allow the
bacteria to adopt an intracellular lifestyle, the capacity of E. coli
to live inside cells is continuously enhanced by the deletion or
inactivation of genes that are inimical to this lifestyle (Day et al.,
2001; Feng et al., 2011; Prosseda et al., 2012). Examples of such
genes include some that encode anti-virulence factors, such as
nadA, nadB, and ompT, and those for metabolic pathways such
as lysine decarboxylation, the end products of which restrict
intracellular growth (Day et al., 2001; Prunier et al., 2007).
Moreover, since flagella are not required for colonisation of the
large intestine or for motility within cells, all shigellae and many
strains of EIEC are non-motile. The capacity of E. coli to adapt to
new environments in this way provides fascinating insights into
the extraordinary versatility of this species as a pathogen.
Enteroaggregative E. coli (EAEC)
This relatively recently discovered E. coli pathotype is mainly
associated with paediatric diarrhoea in developing countries, but
has also been linked to diarrhoea in adults, including travellers
(Okeke and Nataro, 2001; Harrington et al., 2006). EAEC was
originally identified by its characteristic “stacked-brick” pattern
of adherence to tissue culture cells in vitro (Nataro et al.,
1987; Figure 1). This phenotype is attributable to one of several
different hydrophobic aggregative fimbriae, known as AAF/I,
AAF/II, AAF/III, and AAF/IV, encoded by pAA or similar
plasmids. Other putative virulence factors of EAEC include (i)
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FIGURE 1 | Light micrographs showing the distinctive patterns of
adherence of enteroaggregative E. coli (left) and diffusely-adherent E.
coli (right) to cultured epithelial cells (adapted from Nataro et al., 1987).
These patterns were responsible for the names of these pathotypes and were
originally used to identify them in vitro.
a pAA-encoded cytotoxin (Pet), (ii) a pAA-encoded heat-stable
enterotoxin, known as enteroaggregative stable toxin (EAST-1)
that is related to STa of ETEC, but not restricted to EAEC, and
(iii) ShET1, a putative enterotoxin that is also found in Shigella
flexneri (Okeke and Nataro, 2001; Croxen et al., 2013). Although
the pathogenicity of EAEC is evident from foodborne outbreaks
in several countries and infection studies of volunteers (Nataro
et al., 1995; Harrington et al., 2006), the contribution of these
and other putative virulence-associated determinants of EAEC is
not known (Harrington et al., 2006; Croxen et al., 2013). As with
atypical EPEC, EAEC are genetically diverse with the likelihood
that some types are more virulent than others (Boisen et al., 2012;
Zhang et al., 2016).
In 2011, a Shiga toxin-producing derivative of an EAEC strain
of serotype O104:H4, shot to prominence by causing a major
foodborne outbreak of diarrhoea and HUS in Germany, with
serious outcomes for human health and the international food
trade (Buchholz et al., 2011; Rohde et al., 2011).
Few studies of diarrhoea today use the aggregative adherence
phenotype to identify EAEC. Instead most investigators target
the pAA-borne genes, aatA and aggR (that encode a transporter
of a virulence protein and a virulence regulator, respectively), or
the chromosomally-encoded aaiC gene which is also associated
with virulence (Table 1; Panchalingam et al., 2012). Although
PCR-based identification of EAEC is convenient, the presence
or absence of these genes does not necessarily concur with the
aggregative phenotype, nor is it known whether this phenotype
or the presence of aatA, aggR and/or aaiC is the more reliable
predictor of virulence (Weintraub, 2007; Croxen et al., 2013).
This issue is not trivial, because until it is resolved we will lack
a clear definition of what really constitutes EAEC.
Diffusely-Adherent E. coli (DAEC)
As with EAEC, DAEC were originally identified by their
distinctive pattern of adherence to tissue culture cells (Scaletsky
et al., 1984; Nataro et al., 1985, 1987; Figure 1). The first
determinant of diffuse adherence to be identified was an
autotransporter protein, known as AIDA-I, for the Adhesin
Involved in Diffuse Adherence (Benz and Schmidt, 1992).
E. coli strains that express AIDA-1, however, generally carry
other virulence determinants, such as STb, making them ETEC
(Dubreuil, 2010), or the LEE pathogenicity island, making them
EPEC (Servin, 2005, 2014; Table 1). Accordingly, few of these
strains are considered DAEC, despite their phenotype.
AIDA-I-negative DAEC strains typcially express Afa/Dr
adhesins and cause urinary tract infections, placing them in
the UPEC subgroup of ExPEC. Although E. coli that express
afimbrial adhesins (Afa) and Dr fimbriae have been associated
with diarrhoea in children, the specificity of the probes and PCR
primers that were used to detect and identify these bacteria is
questionable, in that they may also react with EAEC and some
other types of E. coli (Servin, 2014). This, and the fact that two
prototypical DAEC strains failed to cause diarrhoea in volunteers
who ingested up to 1010 colony-forming units, casts doubt on
the role of DAEC in diarrhoea, notwithstanding considerable
evidence of the deleterious effects of these bacteria on intestinal
epithelial cells in vitro (reviewed in Servin, 2014).
Adherent-Invasive E. coli (AIEC)
AIEC are unusual amongst DEC pathotypes in that they are not
associated with diarrhoea. Instead they are thought to contribute
to the development of Crohn’s disease, which is a chronic
inflammatory bowel disease. The aetiology of Crohn’s disease is
uncertain, but is likely to involve both host and environmental
factors (Alhagamhmad et al., 2016). AIEC strains are discernible
from other varieties of E. coli, including commensals, by virtue
of their ability to adhere to and invade epithelial cells and to
replicate within macrophages (Martinez-Medina et al., 2009).
Analysis of whole genome sequences of several AIEC isolates,
however, has shown that the AIEC phenotype may not be due
to one or more specific virulence determinants (O’Brien et al.,
2016), suggesting that the distinctive phenotype of these bacteria
may result from metabolic processes that enhances growth in
tissues affected by Crohn’s disease. Thus, although AIEC are
recovered more commonly from patients with Crohn’s disease
than from healthy people, it is unclear whether these bacteria
contribute to the pathogenesis of Crohn’s disease or are merely
adapted to or enriched in intestinal tissue affected by this disease.
E. COLI GENOMICS
The first complete genome sequence of an E. coli strain (E. coli
K-12) was published in 1997 (Blattner et al., 1997). Since then
many thousands of E. coli isolates from a wide range of sources
have also been sequenced, although most of these genomes have
not been fully assembled into a finished and complete genome
sequence. Nevertheless, from the available data we can glean
that the size of the E. coli genome (which includes plasmids
and prophage) ranges from approximately 4.6 million base pairs
(Mbp) to around 5.9 Mbp—a difference of more than 1.3Mbp.
Each individual E. coli strain carries between 4200 and 5500
genes. As more E. coli strains are sequenced the core genome
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(i.e., the backbone of chromosomal genes that are present in
every E. coli strain) shrinks. The size of the core genome
currently stands at fewer than 1500 genes and will to continue
to diminish, albeit slowly, as more strains are sequenced. Genes
that are not part of the core are referred to as the accessory
genome. These include all of the genes that encode bacteriophage
elements, virulence determinants and acquired resistance to
antimicrobials. The E. coli pangenome—the total number of
unique genes that have been identified in E. coli—comprises more
than 22,000 and will continue to increase as more strains are
sequenced.
All of the genes for E. coli virulence determinants were
most likely acquired by horizontal gene transfer from other
bacteria via plasmids, bacteriophages, pathogenicity islands, and
transposons (Leimbach et al., 2013; Table 1). Thus, every E. coli
strain comprises a mosaic of core and accessory genes, with
almost all of the latter, including the virulence determinants of
DEC, being transmissible between strains. For these reasons, it is
inevitable that new pathotypes of DEC will continue to emerge,
either through novel assemblies of E. coli virulence determinants,
as in the case of EHEC (Feng et al., 1998) and Shiga toxin-
producing EAEC (Rohde et al., 2011), or through the acquisition
of virulence genes from other bacterial species.
E. COLI SUBTYPES
Apart from pathotype, individual strains of E. coli can be
subtyped using a variety of criteria that may vary between
individual strains. These include sequence type, serotype,
pulsotype, phage type, and biotype.
Sequence Type
The conserved nature of the E. coli core genome allows
determination of the genetic distance between strains based
on nucleotide polymorphisms in shared genes. For more
than a decade multi-locus sequence typing (MLST), in which
sequence types (STs) are defined on the basis of combinations
of allelic variation in 6–11 so-called “housekeeping genes”
(Maiden et al., 1998), has been the gold standard for DNA
sequence-based typing of bacterial pathogens. Three MLST
schemes have been proposed for E. coli, each based on a
different set of 7–8 genes (Reid et al., 2000; Wirth et al.,
2006; Jaureguy et al., 2008), of which the 7-locus scheme of
Mark Achtman appears to be the most stable and congruent
with whole genome phylogenies (Chaudhuri and Henderson,
2012; Clermont et al., 2015). The principle of MLST has
recently been extended to core gene MLST (cgMLST) (Maiden
et al., 2013), and a new E. coli scheme incorporating
more than 2500 genes is now available (alongside the 7-
locus scheme of Mark Achtman) in the Enterobase database
hosted at the Warwick Medical School (http://enterobase.
warwick.ac.uk). Sequence typing has proved useful in many
settings, e.g., in tracing the spread of particular strains in
different regions, such as E. coli ST131, a multidrug resistant
UPEC clone (Nicolas-Chanoine et al., 2014; Petty et al.,
2014).
Serotype
Serotyping based on antigenic variation in the surface O-
(polysaccharide) and H- (flagella) antigens of E. coli was
previously used for the preliminary identification of DEC
pathotypes. Indeed, much of the early evidence linking EPEC to
the cause of outbreaks of diarrhoea was based on the antigenic
relatedness of strains obtained from patients in different locations
(Robins-Browne, 1987). ETEC, EIEC, EHEC, and EAEC also
belong to a limited number of serotypes, but serotyping is no
longer used for the preliminary identification of these categories,
having been replaced by direct testing for the presence of
virulence-associated genes (Table 1). Moreover, E. coli serotypes
are not immutable, and can change due to mutation or phage-
mediated transduction (Mavris et al., 1997; Kido and Kobayashi,
2000). The superiority of sequence typing over serotyping is
illustrated by the ST131 UPEC pandemic strain, in which most
isolates are serotype O25b:H4, but some are serotype O16:H5
(Nicolas-Chanoine et al., 2014). Importantly, E. coli serotypes
can be reliably predicted from whole genome sequences (Ingle
et al., 2016b). Indeed, in-silico serotyping offers a number
of advantages over traditional serotyping, including the non-
reliance on typing sera that may vary in quality, and the ability
to type strains that do not express the O- or H-antigens in vitro
or that autoagglutinate (Ingle et al., 2016b). For these reasons,
in-silico serotyping is likely to replace traditional serotyping in
future.
Nevertheless, many food microbiology laboratories currently
use serotyping for the preliminary identification of EHEC, most
notably E. coli O157:H7 and the so-called “big six” serogroups
(O26, O45, O103, O111, O121, and O145) of EHEC strains
(Brooks et al., 2005).
Interestingly, even the identification of serotype, together
with the demonstration of a suite of shared virulence genes,
may not provide sufficiently refined information to identify a
particular subclone or clade of EHEC (Manning et al., 2008).
In such instances, further subtyping may be required to track
outbreaks. Traditionally, this has included phage typing (which
is based on the susceptibility of isolates to infection with one
or more specific virulent bacteriophages) or typing based on
restriction fragment length polymorphism (pulsotyping), which
permits the discernment of outbreak strains from background
“noise” (Bender et al., 1997). The value of pulsotyping is
exemplified by PulseNet, a surveillance network of public
health laboratories that use DNA fingerprinting for the early
identification of common sources of foodborne outbreaks of
disease (Swaminathan et al., 2001). More recently, public health
laboratories have been shifting to analysis of whole genome single
nucleotide polymorphisms (SNPs) to trace outbreaks of E. coli
and other foodborne pathogens. This approach first captured
the attention of the international public health community
during the high-profile 2011 outbreak of diarrhoea and HUS
in Germany caused by Shiga toxin producing EAEC (Buchholz
et al., 2011; Rohde et al., 2011), and is now being used for routine
analysis in many laboratories, e.g., to investigate E. coli O157:H7
outbreaks by Public Health England (Cowley et al., 2016), and
the GenomeTrakr project established by the US Food and Drug
Administration (Allard et al., 2016).
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Biotype
Biotyping was once relied upon to group and separate individual
strains of E. coli, particularly in the period before serotyping
became established for this purpose. Currently, biotyping is still
used to distinguish shigellae from other varieties of E. coli.
Although at present there is no comprehensive scheme to predict
E. coli biotype from whole genome sequences, this may be
possible in future should biotyping still be required.
Biochemical profiles also play a central role in the isolation
and preliminary identification of E. coli strains in general, on
media such as McConkey and eosin methylene blue agar, and
of EHEC on sorbitol MaConkey (SMAC) agar and CHROMagar
STEC medium (de Boer et al., 2015).
Pathotype
As mentioned above, the subdivision of DEC into pathotypes
has may uses. However, some isolates do not comply with the
standard pathotyping scheme (Table 2). Such strains include
isolates of EPEC that carry genes for the heat-labile enterotoxin
of ETEC (Dutta et al., 2015); and strains of ETEC and EAEC that
secrete Shiga toxin (Zhang et al., 2007; Buchholz et al., 2011).
Even Shigella dysenteriae type 1, which carries the Shiga toxin
gene on its chromosome is atypical, as far as the Shigella biotype
is concerned, since no other strain in this “genus” produces
this toxin. In addition, Shigella boydii serotype 13 is unusual in
that it carries the LEE pathogenicity island of EPEC (Walters
et al., 2012), although this particular clone is evidently incorrectly
classified, being more closely related to E. albertii than to E.
coli (Hyma et al., 2005). E. albertii is a disctinct Escherichia
species that is characterised in part by its carriage of the LEE
pathogenicity island (Huys et al., 2003).
Hybrid strains of E. coli pathotypes are not surprising given
the mobility of most of the genes that encode virulence in DEC.
What is perhaps more surprising is that hybrids don’t occur
more often. In this regard, DEC strains that infect humans seem
somewhat limited in the combinations of virulence determinants
TABLE 2 | Examples of clinically significant diarrheagenic E. coli strains
that do not comply with established pathotypes.
Strain Comments References
Shiga-toxin producing
EAEC
Some investigators have
deemed these to a new
pathotype named STEAEC
Clements et al., 2012
Shiga-toxin producing
ETEC
Most of these strains are
associated with pig edema
disease
Zhang et al., 2007
LT-producing EPEC We have found this
uncommon hybrid in our
studies of paediatric diarrhoea
(unpublished)
Dutta et al., 2015
Shigella B13 carrying the
LEE pathogenicity island
This clone is more closely
related to E. albertii than to
E. coli
Hyma et al., 2005;
Walters et al., 2012
EAEC, enteroaggregative E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic
E. coli; LEE, locus of enterocyte effacement; LT, heat-labile enterotoxin; STEAEC, Shiga-
toxin producing enteroaggregative E. coli.
that occur together, other than those that are already well
characterised (Table 1). Thus, whereas EPEC, EHEC, ETEC, and
shigellae have all emerged on several different occasions (Pupo
et al., 2000; Sahl et al., 2011; von Mentzer et al., 2014; Ingle et al.,
2016a), hybrids of these are uncommon (Nyholm et al., 2015).
By contrast, some EPEC strains from animals carry colonisation
fimbriae that closely resemble those from ETEC (Adams et al.,
1997), and ETEC from swine may express Shiga toxin as well as
STa and/or STb (Zhang et al., 2007; DebRoy et al., 2010).
A particular limitation of pathotyping concerns its limited
capacity to accommodate new strains that do not comply
with known categories. These include Shiga toxin producing
strains of EAEC, which some authors have assigned to a new
pathotype, designated Shiga-toxin producing enteroaggregative
E. coli (Clements et al., 2012). This is not unreasonable
considering that EHEC, which is a well-accepted pathotype itself,
appears to have emerged relatively recently from EPEC (Feng
et al., 1998), but the nomenclature is unwieldy and inflexible. For
example, it may be more accurate to use the term “Shiga toxin
producing atypical EPEC” for EHEC given the origin of these
strains, and Shiga toxin producing ETEC for the bacteria that
cause oedema disease in pigs.
Another problem with the current definitions of DEC
pathotypes is that some strains are defined in part by negative
criteria. For example, EPEC is defined as having the LEE
pathogenicity island, but lacking Shiga toxin (otherwise it would
be EHEC), and atypical EPEC is defined as lacking both Shiga
toxin and bundle-forming pili (Kaper, 1996; Trabulsi et al., 2002).
We believe that characterising pathogens on the basis of their
lack of one or more virulence determinants may group several
types of distantly related or unrelated bacteria together, and
cause some distinct pathogenic categories with uncharacterised
virulence determinants to be overlooked.
CONCLUSION
The ability to divide E. coli into subtypes is essential to
understand the epidemiology and pathogenesis of particular
clones. The use of sequence typing, biotyping, serotyping, and
pathotyping to group similar bacteria together while separating
them from others is helpful in many circumstances, such as when
tracing outbreaks, but can be misleading when serotypes change
or classification systems struggle to accommodate novel strains.
The subdivision of DEC into pathotypes is critical
for understanding how these bacteria cause disease. The
identification of pathotypes is also invaluable clinically (to
determining prognosis and guide clinical management)
and epidemiologically to detect outbreaks and estimate the
contribution of different types of DEC to the overall burden
of disease, as well as for the control of these diseases by public
health interventions and immunisation (Levine et al., 1983;
Sjöling et al., 2015).
Whole genome sequencing of E. coli strains has vastly
enhanced our understanding of the evolution and pathobiology
of this highly adaptable and versatile species. A major
advantage of whole genome sequencing is that most subtypes
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and other properties can be predicted with a high degree
of accuracy from sequence data. Combined with clinical,
pathological and epidemiological metadata, whole genome
sequencing will also permit elucidation of which strains within
a subtype are more virulence than others. For these reasons,
we expect that some of the typing schemes in current use
will eventually be replaced by a system that is based on
a combination of genes within the core genome (probably
cgMLST) and the accessory genome, comprising major virulence
determinants and associated pathogenic potential. In this regard,
the coordinated sharing of whole genome sequence data via
GenomeTrakr, coupled with standardised extraction of E. coli
typing information including sequence type, serotype, pathotype
and antimicrobial resistance from genome data using tools such
as Enterobase is likely to become the new gold standard for E.
coli analysis. Thus, although whole genome sequencing will not
replace pathotyping in the short-term, it should, together with
clinical, field, and experimental data, be used to enhance our
understanding of what constitutes a pathotype, while allowing for
more pathotypes to be identified by permitting the identification
of particular combinations of genes that are associated with
specific clinical syndromes and pathology. This is particularly
important for loosely defined pathotypes, such as EAEC, DAEC,
AIEC, and atypical EPEC.
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